chr16-2785419-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_152891.3(PRSS33):​c.470G>C​(p.Gly157Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,451,896 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G157R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 7.7e-7 ( 0 hom. )

Consequence

PRSS33
NM_152891.3 missense

Scores

3
9
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.409

Publications

0 publications found
Variant links:
Genes affected
PRSS33 (HGNC:30405): (serine protease 33) Enables serine-type endopeptidase activity. Involved in protein kinase C signaling and proteolysis. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.849

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRSS33NM_152891.3 linkc.470G>C p.Gly157Ala missense_variant Exon 5 of 7 ENST00000682474.1 NP_690851.2 Q8NF86

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRSS33ENST00000682474.1 linkc.470G>C p.Gly157Ala missense_variant Exon 5 of 7 NM_152891.3 ENSP00000507560.1 Q8NF86

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152170
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
7.69e-7
AC:
1
AN:
1299726
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
637652
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26342
American (AMR)
AF:
0.00
AC:
0
AN:
20392
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19364
East Asian (EAS)
AF:
0.00
AC:
0
AN:
32156
South Asian (SAS)
AF:
0.0000151
AC:
1
AN:
66402
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
31434
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3824
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1045980
Other (OTH)
AF:
0.00
AC:
0
AN:
53832
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152170
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41446
American (AMR)
AF:
0.0000654
AC:
1
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68008
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 01, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.470G>C (p.G157A) alteration is located in exon 4 (coding exon 4) of the PRSS33 gene. This alteration results from a G to C substitution at nucleotide position 470, causing the glycine (G) at amino acid position 157 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Uncertain
0.033
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.55
D;D;D
Eigen
Benign
0.069
Eigen_PC
Benign
-0.13
FATHMM_MKL
Benign
0.24
N
LIST_S2
Benign
0.39
.;T;T
M_CAP
Pathogenic
0.41
D
MetaRNN
Pathogenic
0.85
D;D;D
MetaSVM
Uncertain
0.34
D
MutationAssessor
Uncertain
2.1
M;M;.
PhyloP100
0.41
PrimateAI
Uncertain
0.74
T
PROVEAN
Pathogenic
-5.8
D;.;.
REVEL
Uncertain
0.46
Sift
Uncertain
0.0040
D;.;.
Sift4G
Uncertain
0.0040
D;D;.
Polyphen
1.0
D;D;.
Vest4
0.20
MutPred
0.72
Gain of glycosylation at P154 (P = 0.116);Gain of glycosylation at P154 (P = 0.116);.;
MVP
0.93
MPC
0.95
ClinPred
0.92
D
GERP RS
4.7
Varity_R
0.47
gMVP
0.65

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2068861509; hg19: chr16-2835420; API